Mandatory Prescription Limits and Opioid Use After Anterior Cruciate Ligament Reconstruction
- PMID: 34541012
- PMCID: PMC8445535
- DOI: 10.1177/23259671211027546
Mandatory Prescription Limits and Opioid Use After Anterior Cruciate Ligament Reconstruction
Abstract
Background: Because of the need for perioperative pain management, orthopaedic surgeons play an important role in opioid use.
Purpose/hypothesis: To evaluate the impact of opioid-limiting legislation on postoperative opioid use and pain-related complications after anterior cruciate ligament reconstruction (ACLR). The hypothesis was that the opioid-limiting legislation would reduce postoperative opioid use after ACLR.
Study design: Cohort study; level of evidence, 3.
Methods: We retrospectively reviewed patients who underwent ACLR 1 year before and 1 year after Ohio's opioid-limiting legislation, which was passed in August 2017. Clinicians were prohibited from prescribing more than 30 morphine milligram equivalents (MMEs) per day, with a maximum duration of 7 days for adults. The Ohio Automated Rx Reporting System database and patients' medical charts were reviewed for prescriptions of all controlled substances (oral oxycodone, hydrocodone, morphine, codeine, tramadol, and hydromorphone) filled from 30 days before and 90 days after ACLR. The total number of postoperative prescriptions, total MMEs, the number of pills in each patient's prescription, and pain-related complications (emergency department visits, office calls for pain control issues, unplanned readmissions, unplanned surgeries, and provider notes indicating opioid prescription refill demands) were evaluated.
Results: A total of 243 patients (127 prelegislation, 116 postlegislation) were included in the study. There were no significant differences in demographics or preoperative opioid use between the study groups. The number of pills prescribed initially decreased by 34% after legislation (63.5 ± 16.7 [prelegislation] vs 42 ± 15.7 pills [postlegislation]; P < .001). Correspondingly, there was a significant decrease in total quantity of initial prescriptions in the postlegislation period (474.6 ± 123.8 vs 310.7 ± 115.3 MMEs; P < .001). The number of documented pain medication refill demands and pain-related complications did not increase in the postlegislation period (42 prelegislation vs 43 postlegislation; P = .514). Preoperative opioid use was the strongest predictor of opioid-refill demand (odds ratio, 4.19 [95% CI, 1.76-9.99]; P = .001).
Conclusion: After the Ohio legislation was passed limiting opioid prescription, there was a significant reduction in opioids provided for patients undergoing ACLR. In spite of this decrease, no rebound increase in refill demands or postoperative pain-related complications were observed.
Keywords: ACL; anterior cruciate ligament; complication; law; legislation; narcotic; opioid.
© The Author(s) 2021.
Conflict of interest statement
One or more of the authors has declared the following potential conflict of interest or source of funding: S.K. has received education payments from Arthrex. AOSSM checks author disclosures against the Open Payments Database (OPD). AOSSM has not conducted an independent investigation on the OPD and disclaims any liability or responsibility relating thereto.
Figures


References
-
- Alter TH, Ilyas AM. A prospective randomized study analyzing preoperative opioid counseling in pain management after carpal tunnel release surgery. J Hand Surg Am. 2017;42(10):810–815. - PubMed
-
- American Academy of Orthopaedic Surgeons. Opioid use, misuse, and abuse in orthopaedic practice. Published 2015. Accessed August 18, 2018. https://aaos.org/globalassets/about/bylaws-library/information-statement...
-
- Anthony CA, Westermann RW, Bedard N, et al.Opioid demand before and after anterior cruciate ligament reconstruction. Am J Sports Med. 2017;45(13):3098–3103. - PubMed
-
- Beck PR, Nho SJ, Balin J, et al.Postoperative pain management after anterior cruciate ligament reconstruction. J Knee Surg. 2004;17(1):18–23. - PubMed
-
- Blendon RJ, Benson JM. The public and the opioid-abuse epidemic. N Engl J Med. 2018;378(5):407–411. - PubMed
LinkOut - more resources
Full Text Sources